| Symbol | SOPH |
|---|---|
| Name | SOPHIA GENETICS SA |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | LA PIÈCE 12,1180 ROLLE, SAINT-SULPICE, CH-1025, Switzerland |
| Telephone | +41 216941060 |
| Fax | — |
| — | |
| Website | https://www.sophiagenetics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001840706 |
| Description | At SOPHiA GENETICS, we are bringing the power of data and artificial intelligence to healthcare. Our AI platform analyzes multimodal data - including genomics, radiomics, clinical, biological, and digital pathology data - to generate actionable insights for patients with cancer or rare diseases. Today, over 770 healthcare institutions use our cloud-native, consumption-based SaaS platform to bring the power of data-driven medicine to millions of patients across the globe. Beyond the clinical market, our platform is used by BioPharma partners for AI-powered drug discovery, development, and deployment. Additional info from NASDAQ: |
Director Camblong Jurgi 🔴 sold 17.7K shares of SOPHiA GENETICS SA (SOPH) at $5.28 Transaction Date: Jul 07, 2026 | Filing ID: 000255
Read more📋 JURGI CAMBLONG (Director) plans to sell 24K shares of SOPHIA GENETICS SA (at $5.34 each, total $130K) Filed: Jul 07, 2026 | ID: 006944
Read moreCARDOZA GEORGE 🔴 sold 1.6K shares of SOPHiA GENETICS SA (SOPH) at $5.29 Transaction Date: Jul 06, 2026 | Filing ID: 000253
Read moreValente Manuela 🔴 sold 4.2K shares of SOPHiA GENETICS SA (SOPH) at $5.05 Transaction Date: Jul 06, 2026 | Filing ID: 000252
Read moreVerma Abhimanyu 🔴 sold 5.3K shares of SOPHiA GENETICS SA (SOPH) at $5.10 Transaction Date: Jul 06, 2026 | Filing ID: 000251
Read moreXu Zhenyu 🔴 sold 7.4K shares of SOPHiA GENETICS SA (SOPH) at $5.17 Transaction Date: Jul 06, 2026 | Filing ID: 000250
Read moreDirector Muken Ross 🔴 sold 9.8K shares of SOPHiA GENETICS SA (SOPH) at $5.22 Transaction Date: Jul 06, 2026 | Filing ID: 000249
Read morePuylaert Kevin 🔴 sold 216 shares of SOPHiA GENETICS SA (SOPH) at $5.09 Transaction Date: Jul 06, 2026 | Filing ID: 000248
Read moreMenu Philippe 🔴 sold 7.4K shares of SOPHiA GENETICS SA (SOPH) at $5.16 Transaction Date: Jul 06, 2026 | Filing ID: 000247
Read moreDirector Camblong Jurgi 🔴 sold 22.5K shares of SOPHiA GENETICS SA (SOPH) at $5.25 Transaction Date: Jul 06, 2026 | Filing ID: 000246
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07663994 | Analytical Validation of Circulating DNA Analysis Methods: Creation of a Contro… | Na | Healthy Volunteers (Cancer) | Recruiting | 2026-06-30 | 2026-07-31 | ClinicalTrials.gov |
| NCT06525831 | Rein 3D PRINT MECHANICS | Na | Kidney Cancer | Recruiting | 2025-03-07 | 2027-05-07 | ClinicalTrials.gov |
| NCT04994795 | Predictive Multimodal Signatures Associated With Response to Treatment and Prog… | — | Non-small Cell Lung Cancer Metastatic | Active_Not_Recruiting | 2021-08-21 | 2025-02-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| 1 single blood draw after in the inclusion of the participant in the study (Up to 30 mL). | Other | Approved | Healthy Volunteers (Cancer) | RECRUITING | NCT07663994 |
| 1 single blood draw after in the inclusion of the participant in the study (Up to 30 mL). | Other | Approved | Healthy Volunteers (Cancer) | NOT_YET_RECRUITING | NCT07663994 |
| Predictive models (data collection) | Other | Preclinical | Non-small Cell Lung Cancer Metastatic | ACTIVE_NOT_RECRUITING | NCT04994795 |
| Ultrasound exam | Other | Approved | Kidney Cancer | RECRUITING | NCT06525831 |
| MR-elastography exam | Other | Approved | Kidney Cancer | RECRUITING | NCT06525831 |
| Predictive models (data collection) | OTHER | Preclinical | Non-small Cell Lung Cancer Metastatic | ACTIVE_NOT_RECRUITING | NCT04994795 |